Week in review: MicroShunt use in kids, global cataract burden, verteporfin and COVID-19

The PreserFlo MicroShunt is being studied for use in children, the global burden of cataract continues to rise, and verteporfin has potential against the SARS-CoV-2 virus.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553